Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications
Open Access
- 6 October 2020
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 22 (12) , 1-12
Abstract
Purpose of the Review: Inflammatory cytokines play a major role in atherosclerotic plaque progression. This review summarizes the rationale for personalized anti-inflammatory therapy.Recent Findings: Systemic inflammatory parameters may be used to follow the clinical outcome in primary and secondary prevention. Medical therapy, both in patients with stable cardiovascular disease, or with acute events, may be tailored taking into consideration the level and course of systemic inflammatory mediators. There is significant space for improvement in primary prevention and in the treatment of patients who have suffered from severe cardiovascular events, paying attention to not only blood pressure and cholesterol levels but also including inflammatory parameters in our clinical analysis.Summary: The potential exists to alter the course of atherosclerosis with anti-inflammatory drugs. With increased understanding of the specific mechanisms that regulate the relationship between inflammation and atherosclerosis, new, more effective and specific anti-inflammatory treatment may become available.Keywords
Funding Information
- Università degli Studi di Roma La Sapienza
This publication has 112 references indexed in Scilit:
- Inflammation in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Vorapaxar in the Secondary Prevention of Atherothrombotic EventsNew England Journal of Medicine, 2012
- Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in miceJournal of Clinical Investigation, 2012
- Mechanical events within the arterial wall under the forces of pulsatile flow: A reviewJournal of the Mechanical Behavior of Biomedical Materials, 2011
- PDGF-BB and TGF-β1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stressProceedings of the National Academy of Sciences, 2011
- Pathogen Recognition and Inflammatory Signaling in Innate Immune DefensesClinical Microbiology Reviews, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Differential Accumulation of Proteoglycans and Hyaluronan in Culprit LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986